132 related articles for article (PubMed ID: 27417181)
1. Characteristic Analysis of Intestinal Transport in Enterocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells.
Kodama N; Iwao T; Katano T; Ohta K; Yuasa H; Matsunaga T
Drug Metab Dispos; 2016 Oct; 44(10):0. PubMed ID: 27417181
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mitogen-activated protein kinase kinase, DNA methyltransferase, and transforming growth factor-β promotes differentiation of human induced pluripotent stem cells into enterocytes.
Kodama N; Iwao T; Kabeya T; Horikawa T; Niwa T; Kondo Y; Nakamura K; Matsunaga T
Drug Metab Pharmacokinet; 2016 Jun; 31(3):193-200. PubMed ID: 27161454
[TBL] [Abstract][Full Text] [Related]
3. Generation of enterocyte-like cells with pharmacokinetic functions from human induced pluripotent stem cells using small-molecule compounds.
Iwao T; Kodama N; Kondo Y; Kabeya T; Nakamura K; Horikawa T; Niwa T; Kurose K; Matsunaga T
Drug Metab Dispos; 2015 Apr; 43(4):603-10. PubMed ID: 25650381
[TBL] [Abstract][Full Text] [Related]
4. Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells.
Negoro R; Takayama K; Nagamoto Y; Sakurai F; Tachibana M; Mizuguchi H
Biochem Biophys Res Commun; 2016 Apr; 472(4):631-6. PubMed ID: 26966071
[TBL] [Abstract][Full Text] [Related]
5. Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies.
Yoshida S; Honjo T; Iino K; Ishibe R; Leo S; Shimada T; Watanabe T; Ishikawa M; Maeda K; Kusuhara H; Shiraki N; Kume S
Stem Cell Reports; 2021 Feb; 16(2):295-308. PubMed ID: 33513361
[TBL] [Abstract][Full Text] [Related]
6. Generation of Intestinal Organoids Suitable for Pharmacokinetic Studies from Human Induced Pluripotent Stem Cells.
Onozato D; Yamashita M; Nakanishi A; Akagawa T; Kida Y; Ogawa I; Hashita T; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Nov; 46(11):1572-1580. PubMed ID: 29615438
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of carboxylesterase in human induced pluripotent stem cell-derived enterocytes.
Kabeya T; Matsumura W; Iwao T; Hosokawa M; Matsunaga T
Biochem Biophys Res Commun; 2017 Apr; 486(1):143-148. PubMed ID: 28285137
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP Signaling Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Intestinal Epithelial Cells.
Kabeya T; Qiu S; Hibino M; Nagasaki M; Kodama N; Iwao T; Matsunaga T
Drug Metab Dispos; 2018 Oct; 46(10):1411-1419. PubMed ID: 30068521
[TBL] [Abstract][Full Text] [Related]
9. [Utilization of Human iPS Cells for Evaluation of Drug Disposition and Mucosal Damages in the Small Intestine].
Iwao T
Yakugaku Zasshi; 2023; 143(3):243-247. PubMed ID: 36858557
[TBL] [Abstract][Full Text] [Related]
10. [Development of an In Vitro System for Evaluating Intestinal Drug Disposition Using Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells].
Iwao T
Yakugaku Zasshi; 2018; 138(10):1241-1247. PubMed ID: 30270266
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells.
Kondo S; Mizuno S; Hashita T; Iwao T; Matsunaga T
Biol Open; 2020 Jan; 9(1):. PubMed ID: 31919043
[TBL] [Abstract][Full Text] [Related]
12. Generation of enterocyte-like cells from human induced pluripotent stem cells for drug absorption and metabolism studies in human small intestine.
Ozawa T; Takayama K; Okamoto R; Negoro R; Sakurai F; Tachibana M; Kawabata K; Mizuguchi H
Sci Rep; 2015 Nov; 5():16479. PubMed ID: 26559489
[TBL] [Abstract][Full Text] [Related]
13. An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes.
Qiu S; Li Y; Imakura Y; Mima S; Hashita T; Iwao T; Matsunaga T
Cells; 2021 Apr; 10(4):. PubMed ID: 33917333
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human induced pluripotent stem cells into functional enterocyte-like cells using a simple method.
Iwao T; Toyota M; Miyagawa Y; Okita H; Kiyokawa N; Akutsu H; Umezawa A; Nagata K; Matsunaga T
Drug Metab Pharmacokinet; 2014; 29(1):44-51. PubMed ID: 23822979
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells.
Kabeya T; Mima S; Imakura Y; Miyashita T; Ogura I; Yamada T; Yasujima T; Yuasa H; Iwao T; Matsunaga T
Drug Metab Pharmacokinet; 2020 Aug; 35(4):374-382. PubMed ID: 32651148
[TBL] [Abstract][Full Text] [Related]
16. iPSC-Derived Enterocyte-like Cells for Drug Absorption and Metabolism Studies.
Macedo MH; Araújo F; Martínez E; Barrias C; Sarmento B
Trends Mol Med; 2018 Aug; 24(8):696-708. PubMed ID: 29945758
[TBL] [Abstract][Full Text] [Related]
17. Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction.
Takayama K; Negoro R; Yamashita T; Kawai K; Ichikawa M; Mori T; Nakatsu N; Harada K; Ito S; Yamada H; Yamaura Y; Hirata K; Ishida S; Mizuguchi H
Cell Mol Gastroenterol Hepatol; 2019; 8(3):513-526. PubMed ID: 31228606
[TBL] [Abstract][Full Text] [Related]
18. New Maintenance Culture Method for Intestinal Stem Cells Derived from Human Induced Pluripotent Stem Cells.
Mizuno S; Jinnoh Y; Arita A; Qiu S; Hashita T; Hori E; Iwao T; Matsunaga T
Biol Pharm Bull; 2024; 47(1):120-129. PubMed ID: 38171772
[TBL] [Abstract][Full Text] [Related]
19. Human small intestinal epithelial cells differentiated from adult intestinal stem cells as a novel system for predicting oral drug absorption in humans.
Takenaka T; Harada N; Kuze J; Chiba M; Iwao T; Matsunaga T
Drug Metab Dispos; 2014 Nov; 42(11):1947-54. PubMed ID: 25200868
[TBL] [Abstract][Full Text] [Related]
20. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES
Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
